Jingjing Zhu Xinyu Zhu Fengyang Xie Yi Ding Huina Lu Yan Dong Ping Li Jianfei Fu Aibin Liang Yu Zeng Bing Xiu
10.3389/pore.2023.1611070
Pathol Oncol Res
2023 Apr 19;29:1611070.
btk inhibitor waldenström macroglobulinemia ascites circulating tumor dna (ctdna) resistance
CC BY
https://pubmed.ncbi.nlm.nih.gov/37151353/
Circulating Tumor DNA / genetics Lymphoma, B-Cell Waldenstrom Macroglobulinemia / drug therapy Waldenstrom Macroglobulinemia / genetics
Circulating Tumor DNA / genetics Lymphoma, B-Cell Waldenstrom Macroglobulinemia / drug therapy Waldenstrom Macroglobulinemia / genetics Case Reports Agammaglobulinaemia Tyrosine Kinase / antagonists & inhibitors Ascites Disease Progression Humans Male Middle Aged Protein Kinase Inhibitors / therapeutic use Circulating Tumor DNA Agammaglobulinaemia Tyrosine Kinase Protein Kinase Inhibitors
PMC10154527
37151353
Case report: Circulating tumor DNA technology displays temporal and spatial heterogeneity in Waldenström macroglobulinemia during treatment with BTK inhibitors
2023